Showing 1 - 1 results of 1 for search 'Heinrich Karl Spiss', query time: 0.02s Refine Results
  1. 1
    Favorable benefit–risk ratio with teriflunomide treatment in relapsing-remitting multiple sclerosis: Results of the 2-year, multicenter, prospective, noninterventional TAURUS MS study in Austria

    Favorable benefit–risk ratio with teriflunomide treatment in relapsing-remitting multiple sclerosis: Results of the 2-year, multicenter, prospective, noninterventional TAURUS MS st... by Michael Guger, Michael Matthias Ackerl, Martin Heine, Christiane Hofinger-Renner, Heinrich Karl Spiss, Andrea Taut, Karin Unger, Fritz Leutmezer

    Published 2022-06-01
    Get full text
    Article

Search Tools: